Nirob K. Saha, William S. Salvia, Dominik Konkolewicz, C. Scott Hartley. “Exchange in transient covalent assembly.” ChemRxiv (). https://doi.org/10.26434/chemrxiv.15007684/v1

Methyl 3-hydroxybenzoate
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CHCl₃ δ 7.27 and 77.2 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H NMR (400 MHz, CDCl₃) δ 7.63 (dd, J = 2.1, 2.1 Hz, 1H), 7.59 (dd, J = 8.1, 2.6 Hz, 1H), 7.30 (dd, J = 7.9, 7.9 Hz, 1H), 7.11 (dd, J = 8.1, 2.6 Hz, 1H), 6.48 (s, 1H), 3.92 (s, 3H)
¹³C NMR (101 MHz, CDCl₃) δ 168.04, 156.33, 131.30, 129.98, 121.98, 120.79, 116.65, 52.71
SI, pp. S3–S4
mAc methyl ester
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CHCl₃ δ 7.27 and 77.2 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H NMR (500 MHz, CDCl₃) δ 7.60 (dd, J = 7.7, 1.0 Hz, 1H), 7.53 (dd, J = 2.7, 1.5 Hz, 1H), 7.30 (dd, J = 7.9, 7.9 Hz, 1H), 7.09 (dd, J = 8.3, 1.0 Hz, 1H), 4.14 (dd, J = 5.7, 3.9 Hz, 2H), 3.88 (dd, J = 28.1, 0.6 Hz, 3H), 3.84 (dd, J = 5.7, 4.0 Hz, 3H), 3.77 – 3.55 (m, 82H), 3.52 (dd, J = 5.8, 3.6 Hz, 3H), 3.35 (s, 3H)
¹³C NMR (101 MHz, CDCl₃) δ 166.92, 158.79, 131.41, 129.42, 122.17, 120.11, 114.78, 72.55, 71.96, 70.89, 70.71, 70.66, 70.64, 70.60, 70.55, 70.39, 69.66, 67.67, 61.75, 59.06, 52.19
SI, pp. S3–S4
mAc
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H NMR (400 MHz, Acetone-d₆) δ 7.64 (d, J = 7.6 Hz, 1H), 7.59 (s, 1H), 7.44 (dd, J = 7.9, 2.7 Hz, 1H), 7.23 (dd, J = 8.3, 2.7 Hz, 1H), 4.22 (dd, J = 4.7, 4.7 Hz, 2H), 3.87 (dd, J = 4.8, 4.8 Hz, 2H), 3.71 – 3.45 (m, 64H), 3.30 (s, 3H)
¹³C NMR (101 MHz, Acetone-d₆) δ 205.87, 167.09, 159.68, 132.47, 130.12, 122.45, 120.06, 115.63, 72.33, 71.12, 70.97, 70.92, 70.74, 69.93, 68.32, 58.47, 30.11, 29.92, 29.72, 29.53, 29.34, 29.15, 28.95
SI, pp. S3–S5
mAc dimerization and hydrolysis
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H and ¹³C NMR monitoring, sample mAc (102 mM), pyridine-d₅ (62 mM), ethylene carbonate (104 mM), and one equiv. EDC (105 mM) in 80:20 acetone-d₆:D₂O at rt
¹³C NMR calibration factors mAc: 0.509 for the signal at 124.4 ppm; mAn: 0.544 for the signal at 118.2 ppm
¹H and ¹³C NMR monitoring, 57 min mAn: 39.2 mM; mAc: 0 mM
¹H and ¹³C NMR monitoring, 1532 min mAn: 22.4 mM; mAc: 24.7 mM
¹H and ¹³C NMR monitoring, 2744 min mAn: 16.9 mM; mAc: 47.2 mM
¹H and ¹³C NMR monitoring, 4265 min mAn: 9.46 mM; mAc: 50.8 mM
¹H and ¹³C NMR monitoring, 5609 min mAn: 9.57 mM; mAc: 69.0 mM
¹H and ¹³C NMR monitoring, 7061 min mAn: 5.21 mM; mAc: 69.8 mM
¹H and ¹³C NMR monitoring, 8468 min mAn: 2.57 mM; mAc: 74.5 mM
¹H and ¹³C NMR monitoring, 10004 min mAn: 1.47 mM; mAc: 75.3 mM
¹H and ¹³C NMR monitoring, 12898 min mAn: 1.29 mM; mAc: 76.6 mM
¹H and ¹³C NMR monitoring, 15562 min mAn: 1.14 mM; mAc: 80.5 mM
SI, pp. S3, S5
pAc dimerization and hydrolysis
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H and ¹³C NMR monitoring, sample pAc (101 mM), pyridine-d₅ (59 mM), ethylene carbonate (106 mM), and one equiv. EDC (104 mM) in 80:20 acetone-d₆:D₂O at rt
¹³C NMR calibration factors pAc: 0.230 for the signal at 134.2 ppm; pAn: 0.240 for the signal at 135.2 ppm
¹H and ¹³C NMR monitoring, 61 min pAn: 46.8 mM; pAc: 0 mM
¹H and ¹³C NMR monitoring, 1407 min pAn: 45.6 mM; pAc: 0 mM
¹H and ¹³C NMR monitoring, 2937 min pAn: 37.9 mM; pAc: 0 mM
¹H and ¹³C NMR monitoring, 4273 min pAn: 40.3 mM; pAc: 0 mM
¹H and ¹³C NMR monitoring, 5819 min pAn: 38.8 mM; pAc: 1.32 mM
¹H and ¹³C NMR monitoring, 7196 min pAn: 34.8 mM; pAc: 4.35 mM
¹H and ¹³C NMR monitoring, 8510 min pAn: 38.0 mM; pAc: 7.75 mM
¹H and ¹³C NMR monitoring, 11554 min pAn: 32.2 mM; pAc: 10.9 mM
¹H and ¹³C NMR monitoring, 14269 min pAn: 32.4 mM; pAc: 11.7 mM
¹H and ¹³C NMR monitoring, 18980 min pAn: 33.0 mM; pAc: 17.5 mM
¹H and ¹³C NMR monitoring, 21813 min pAn: 29.6 mM; pAc: 17.8 mM
¹H and ¹³C NMR monitoring, 26174 min pAn: 29.4 mM; pAc: 22.3 mM
¹H and ¹³C NMR monitoring, 28972 min pAn: 25.9 mM; pAc: 24.7 mM
¹H and ¹³C NMR monitoring, 34716 min pAn: 24.6 mM; pAc: 30.0 mM
¹H and ¹³C NMR monitoring, 44549 min pAn: 24.5 mM; pAc: 40.2 mM
SI, pp. S3, S5–S6
pDAc polymerization and hydrolysis
NMR concentration definition For the polymers, apparent concentrations of the anhydride functional groups were monitored, not polymer chains
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H and ¹³C NMR monitoring, sample pDAc (102 mM), pyridine-d₅ (61 mM), ethylene carbonate (104 mM), and one equiv. EDC (104 mM) in 80:20 acetone-d₆:D₂O at rt
¹³C NMR calibration factors pDAc: 0.093 for the signal at 134.2 ppm; pP: 0.434 for the signal at 166.7 ppm
¹H and ¹³C NMR monitoring, 59 min pP: 45.9 mM; pDAc: 13.8 mM
¹H and ¹³C NMR monitoring, 1403 min pP: 45.5 mM; pDAc: 15.0 mM
¹H and ¹³C NMR monitoring, 2931 min pP: 44.9 mM; pDAc: 16.3 mM
¹H and ¹³C NMR monitoring, 4241 min pP: 44.4 mM; pDAc: 17.3 mM
¹H and ¹³C NMR monitoring, 5616 min pP: 44.2 mM; pDAc: 17.8 mM
¹H and ¹³C NMR monitoring, 7267 min pP: 43.6 mM; pDAc: 18.3 mM
¹H and ¹³C NMR monitoring, 8819 min pP: 43.0 mM; pDAc: 19.4 mM
¹H and ¹³C NMR monitoring, 11971 min pP: 42.1 mM; pDAc: 21.3 mM
¹H and ¹³C NMR monitoring, 14790 min pP: 41.3 mM; pDAc: 23.0 mM
¹H and ¹³C NMR monitoring, 19178 min pP: 40.4 mM; pDAc: 25.4 mM
¹H and ¹³C NMR monitoring, 20315 min pP: 39.9 mM; pDAc: 26.2 mM
¹H and ¹³C NMR monitoring, 21758 min pP: 39.4 mM; pDAc: 26.8 mM
¹H and ¹³C NMR monitoring, 26079 min pP: 38.5 mM; pDAc: 29.1 mM
¹H and ¹³C NMR monitoring, 29023 min pP: 37.9 mM; pDAc: 30.7 mM
¹H and ¹³C NMR monitoring, 34655 min pP: 36.4 mM; pDAc: 33.6 mM
¹H and ¹³C NMR monitoring, 72276 min pP: 28.0 mM; pDAc: 49.8 mM
¹H and ¹³C NMR monitoring, 93742 min pP: 23.6 mM; pDAc: 58.0 mM
¹H and ¹³C NMR monitoring, 103777 min pP: 21.7 mM; pDAc: 61.6 mM
Main, p. 10; SI, pp. S3, S6–S7
Addition of 2.5 equiv. mAc to pAn
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H and ¹³C NMR monitoring, sample pAc (101 mM), pyridine-d₅ (64 mM), ethylene carbonate (104 mM), one equiv. EDC (104 mM), and mAc (233 mM) in 80:20 acetone-d₆:D₂O at rt
¹³C NMR quantitation signals and calibration factors pAn: 135.25 ppm, c 0.24/2; pAc: 134.2 ppm, c 0.23; mAc: 124.42 ppm, c 0.544; pmAn: 135.4 ppm, c 0.24; mAn: 118.20 ppm, c 0.509/2
¹H and ¹³C NMR monitoring, 87 min pAn: 42.2 mM; pAc: 0 mM; mAc: --; pmAn: --; mAn: --
¹H and ¹³C NMR monitoring, 5624 min pAn: 42.2 mM; pAc: 0 mM; mAc: --; pmAn: --; mAn: --
¹H and ¹³C NMR monitoring, 5700 min; 69 min after mAc addition pAn: 32.8 mM; pAc: 0 mM; mAc: 256 mM; pmAn: 0 mM; mAn: 0 mM
¹H and ¹³C NMR monitoring, 7092 min; 1461 min after mAc addition pAn: 18.4 mM; pAc: 18.2 mM; mAc: 212 mM; pmAn: 7.79 mM; mAn: 4.43 mM
¹H and ¹³C NMR monitoring, 8641 min; 3010 min after mAc addition pAn: 15.2 mM; pAc: 36.1 mM; mAc: 218 mM; pmAn: 10.1 mM; mAn: 10.3 mM
¹H and ¹³C NMR monitoring, 10002 min; 4371 min after mAc addition pAn: 10.3 mM; pAc: 44.7 mM; mAc: 235 mM; pmAn: 10.6 mM; mAn: 9.40 mM
¹H and ¹³C NMR monitoring, 11457 min; 5826 min after mAc addition pAn: 5.24 mM; pAc: 45.7 mM; mAc: 202 mM; pmAn: 9.42 mM; mAn: 7.68 mM
¹H and ¹³C NMR monitoring, 13020 min; 7389 min after mAc addition pAn: 4.61 mM; pAc: 48.5 mM; mAc: 200 mM; pmAn: 9.38 mM; mAn: 8.93 mM
¹H and ¹³C NMR monitoring, 15782 min; 10151 min after mAc addition pAn: 4.23 mM; pAc: 53.6 mM; mAc: 216 mM; pmAn: 8.79 mM; mAn: 8.10 mM
¹H and ¹³C NMR monitoring, 17364 min; 11733 min after mAc addition pAn: 4.06 mM; pAc: 63.7 mM; mAc: 238 mM; pmAn: 10.73 mM; mAn: 7.08 mM
¹H and ¹³C NMR monitoring, 18663 min; 13032 min after mAc addition pAn: 3.47 mM; pAc: 56.1 mM; mAc: 204 mM; pmAn: 7.42 mM; mAn: 8.00 mM
¹H and ¹³C NMR monitoring, 21909 min; 16278 min after mAc addition pAn: 1.86 mM; pAc: 50.5 mM; mAc: 204 mM; pmAn: 9.15 mM; mAn: 4.26 mM
¹H and ¹³C NMR monitoring, 25854 min; 20223 min after mAc addition pAn: 2.74 mM; pAc: 64.4 mM; mAc: 228 mM; pmAn: 6.56 mM; mAn: 4.10 mM
¹H and ¹³C NMR monitoring, 30246 min; 24615 min after mAc addition pAn: 1.27 mM; pAc: 66.3 mM; mAc: 232 mM; pmAn: 4.01 mM; mAn: 1.76 mM
¹H and ¹³C NMR monitoring, 34658 min; 29027 min after mAc addition pAn: 1.49 mM; pAc: 68.1 mM; mAc: 235 mM; pmAn: 3.89 mM; mAn: 0 mM
SI, pp. S3, S7–S8
Addition of 5.0 equiv. mAc to pAn
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H and ¹³C NMR monitoring, sample pAc (102 mM), pyridine-d₅ (62 mM), ethylene carbonate (103 mM), one equiv. EDC (104 mM), and mAc (513 mM) in 80:20 acetone-d₆:D₂O at rt
¹³C NMR quantitation signals and calibration factors pAn: 135.25 ppm, c 0.24/2; pAc: 134.2 ppm, c 0.23; mAc: 124.42 ppm, c 0.544; pmAn: 135.4 ppm, c 0.24; mAn: 118.20 ppm, c 0.509/2
¹H and ¹³C NMR monitoring, 82 min pAn: 38.9 mM; pAc: 0 mM; mAc: --; pmAn: --; mAn: --
¹H and ¹³C NMR monitoring, 5690 min pAn: 36.2 mM; pAc: 0 mM; mAc: --; pmAn: --; mAn: --
¹H and ¹³C NMR monitoring, 5767 min; 71 min after mAc addition pAn: 29.2 mM; pAc: 0 mM; mAc: 555 mM; pmAn: 0 mM; mAn: 0 mM
¹H and ¹³C NMR monitoring, 7084 min; 1388 min after mAc addition pAn: 22.3 mM; pAc: 16.5 mM; mAc: 562 mM; pmAn: 4.88 mM; mAn: 2.86 mM
¹H and ¹³C NMR monitoring, 8666 min; 2970 min after mAc addition pAn: 14.2 mM; pAc: 27.5 mM; mAc: 489 mM; pmAn: 8.91 mM; mAn: 9.56 mM
¹H and ¹³C NMR monitoring, 10003 min; 4307 min after mAc addition pAn: 9.47 mM; pAc: 34.6 mM; mAc: 461 mM; pmAn: 6.40 mM; mAn: 8.36 mM
¹H and ¹³C NMR monitoring, 11451 min; 5755 min after mAc addition pAn: 7.47 mM; pAc: 43.3 mM; mAc: 509 mM; pmAn: 7.10 mM; mAn: 10.9 mM
¹H and ¹³C NMR monitoring, 13008 min; 7312 min after mAc addition pAn: 7.73 mM; pAc: 61.7 mM; mAc: 590 mM; pmAn: 7.56 mM; mAn: 12.4 mM
¹H and ¹³C NMR monitoring, 15774 min; 10078 min after mAc addition pAn: 2.93 mM; pAc: 57.0 mM; mAc: 496 mM; pmAn: 4.70 mM; mAn: 10.9 mM
¹H and ¹³C NMR monitoring, 17352 min; 11656 min after mAc addition pAn: 3.12 mM; pAc: 63.7 mM; mAc: 543 mM; pmAn: 5.82 mM; mAn: 9.35 mM
¹H and ¹³C NMR monitoring, 18660 min; 12964 min after mAc addition pAn: 2.08 mM; pAc: 65.9 mM; mAc: 548 mM; pmAn: 4.15 mM; mAn: 9.49 mM
¹H and ¹³C NMR monitoring, 21923 min; 16227 min after mAc addition pAn: 1.62 mM; pAc: 75.8 mM; mAc: 622 mM; pmAn: 3.81 mM; mAn: 9.91 mM
¹H and ¹³C NMR monitoring, 25899 min; 20203 min after mAc addition pAn: 0.956 mM; pAc: 61.9 mM; mAc: 487 mM; pmAn: 1.17 mM; mAn: 5.65 mM
¹H and ¹³C NMR monitoring, 30256 min; 24560 min after mAc addition pAn: 0 mM; pAc: 71.3 mM; mAc: 544 mM; pmAn: 0 mM; mAn: 4.27 mM
¹H and ¹³C NMR monitoring, 34646 min; 28950 min after mAc addition pAn: 0 mM; pAc: 78.0 mM; mAc: 584 mM; pmAn: 0 mM; mAn: 4.89 mM
SI, pp. S3, S8–S9
Addition of 10.0 equiv. mAc to pAn
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H and ¹³C NMR monitoring, sample pAc (102 mM), pyridine-d₅ (62 mM), ethylene carbonate (103 mM), one equiv. EDC (104 mM), and mAc (1005 mM) in 80:20 acetone-d₆:D₂O at rt
¹³C NMR quantitation signals and calibration factors pAn: 135.25 ppm, c 0.24/2; pAc: 134.2 ppm, c 0.23; mAc: 124.42 ppm, c 0.544; pmAn: 135.4 ppm, c 0.24; mAn: 118.20 ppm, c 0.509/2
¹H and ¹³C NMR monitoring, 94 min pAn: 46.5 mM; pAc: 0 mM; mAc: --; pmAn: --; mAn: --
¹H and ¹³C NMR monitoring, 5768 min pAn: 34.4 mM; pAc: 0 mM; mAc: --; pmAn: --; mAn: --
¹H and ¹³C NMR monitoring, 5846 min; 75 min after mAc addition pAn: 30.4 mM; pAc: 0 mM; mAc: 785 mM; pmAn: 0 mM; mAn: 0 mM
¹H and ¹³C NMR monitoring, 7089 min; 1318 min after mAc addition pAn: 22.4 mM; pAc: 12.0 mM; mAc: 852 mM; pmAn: 0 mM; mAn: 0 mM
¹H and ¹³C NMR monitoring, 8672 min; 2901 min after mAc addition pAn: 18.4 mM; pAc: 19.7 mM; mAc: 747 mM; pmAn: 5.85 mM; mAn: 5.48 mM
¹H and ¹³C NMR monitoring, 10002 min; 4231 min after mAc addition pAn: 12.2 mM; pAc: 26.1 mM; mAc: 693 mM; pmAn: 7.78 mM; mAn: 8.85 mM
¹H and ¹³C NMR monitoring, 11448 min; 5677 min after mAc addition pAn: 10.9 mM; pAc: 35.8 mM; mAc: 703 mM; pmAn: 5.45 mM; mAn: 7.97 mM
¹H and ¹³C NMR monitoring, 13016 min; 7245 min after mAc addition pAn: 8.12 mM; pAc: 41.6 mM; mAc: 753 mM; pmAn: 3.28 mM; mAn: 11.1 mM
¹H and ¹³C NMR monitoring, 15784 min; 10013 min after mAc addition pAn: 5.20 mM; pAc: 46.0 mM; mAc: 723 mM; pmAn: 9.12 mM; mAn: 13.5 mM
¹H and ¹³C NMR monitoring, 17356 min; 11585 min after mAc addition pAn: 3.31 mM; pAc: 51.3 mM; mAc: 774 mM; pmAn: 4.74 mM; mAn: 15.3 mM
¹H and ¹³C NMR monitoring, 18658 min; 12887 min after mAc addition pAn: 3.81 mM; pAc: 52.9 mM; mAc: 725 mM; pmAn: 5.68 mM; mAn: 12.1 mM
¹H and ¹³C NMR monitoring, 21936 min; 16165 min after mAc addition pAn: 2.46 mM; pAc: 60.6 mM; mAc: 756 mM; pmAn: 5.78 mM; mAn: 10.2 mM
¹H and ¹³C NMR monitoring, 25896 min; 20125 min after mAc addition pAn: 0.454 mM; pAc: 65.3 mM; mAc: 769 mM; pmAn: 5.91 mM; mAn: 13.1 mM
¹H and ¹³C NMR monitoring, 30277 min; 24506 min after mAc addition pAn: 1.38 mM; pAc: 62.7 mM; mAc: 729 mM; pmAn: 3.44 mM; mAn: 8.31 mM
¹H and ¹³C NMR monitoring, 34730 min; 28959 min after mAc addition pAn: 0 mM; pAc: 61.2 mM; mAc: 686 mM; pmAn: 0 mM; mAn: 5.00 mM
SI, pp. S3, S9–S10
Addition of 5.0 equiv. mAc to pP
NMR concentration definition For the polymers, apparent concentrations of the anhydride functional groups were monitored, not polymer chains
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H and ¹³C NMR monitoring, sample pAc (101 mM), pyridine-d₅ (62 mM), ethylene carbonate (102 mM), one equiv. EDC (102 mM), and mAc (516 mM) in 80:20 acetone-d₆:D₂O at rt
¹³C NMR quantitation signals and calibration factors pP: 166.74 ppm, c 0.434/2; pDAc: 134.2 ppm, c 0.093; mAc: 124.64 ppm, c 0.544; pPmAn: 167 ppm, c 0.434; mAn: 124.20 ppm, c 0.6/2
¹H and ¹³C NMR monitoring, 62 min pP: 46.1 mM; pDAc: 19.9 mM; mAc: --; pPmAn: --; mAn: --
¹H and ¹³C NMR monitoring, 5593 min pP: 48.3 mM; pDAc: 22.3 mM; mAc: --; pPmAn: --; mAn: --
¹H and ¹³C NMR monitoring, 5672 min; 68 min after mAc addition pP: 45.0 mM; pDAc: 18.2 mM; mAc: 577 mM; pPmAn: 0 mM; mAn: 0 mM
¹H and ¹³C NMR monitoring, 5730 min; 126 min after mAc addition pP: 39.0 mM; pDAc: 19.3 mM; mAc: 575 mM; pPmAn: 0 mM; mAn: 0 mM
¹H and ¹³C NMR monitoring, 5794 min; 190 min after mAc addition pP: 39.2 mM; pDAc: 19.4 mM; mAc: 572 mM; pPmAn: 0 mM; mAn: 0 mM
¹H and ¹³C NMR monitoring, 5852 min; 248 min after mAc addition pP: 35.6 mM; pDAc: 18.5 mM; mAc: 526 mM; pPmAn: 0 mM; mAn: 0 mM
¹H and ¹³C NMR monitoring, 7052 min; 1448 min after mAc addition pP: 29.9 mM; pDAc: 29.0 mM; mAc: 551 mM; pPmAn: 6.02 mM; mAn: 0 mM
¹H and ¹³C NMR monitoring, 8483 min; 2879 min after mAc addition pP: 22.5 mM; pDAc: 37.6 mM; mAc: 512 mM; pPmAn: 8.67 mM; mAn: 8.66 mM
¹H and ¹³C NMR monitoring, 9954 min; 4350 min after mAc addition pP: 17.8 mM; pDAc: 47.4 mM; mAc: 498 mM; pPmAn: 10.5 mM; mAn: 12.8 mM
¹H and ¹³C NMR monitoring, 11489 min; 5885 min after mAc addition pP: 14.2 mM; pDAc: 50.5 mM; mAc: 495 mM; pPmAn: 12.9 mM; mAn: 17.6 mM
¹H and ¹³C NMR monitoring, 13064 min; 7460 min after mAc addition pP: 9.55 mM; pDAc: 43.5 mM; mAc: 444 mM; pPmAn: 15.0 mM; mAn: 16.2 mM
¹H and ¹³C NMR monitoring, 14303 min; 8699 min after mAc addition pP: 8.46 mM; pDAc: 62.2 mM; mAc: 504 mM; pPmAn: 14.0 mM; mAn: 17.5 mM
¹H and ¹³C NMR monitoring, 15536 min; 9932 min after mAc addition pP: 7.39 mM; pDAc: 59.7 mM; mAc: 481 mM; pPmAn: 12.0 mM; mAn: 13.3 mM
¹H and ¹³C NMR monitoring, 17151 min; 11547 min after mAc addition pP: 5.61 mM; pDAc: 57.4 mM; mAc: 454 mM; pPmAn: 9.91 mM; mAn: 14.1 mM
¹H and ¹³C NMR monitoring, 18569 min; 12965 min after mAc addition pP: 7.14 mM; pDAc: 61.0 mM; mAc: 468 mM; pPmAn: 11.2 mM; mAn: 13.0 mM
¹H and ¹³C NMR monitoring, 20045 min; 14441 min after mAc addition pP: 5.61 mM; pDAc: 67.0 mM; mAc: 500 mM; pPmAn: 10.2 mM; mAn: 12.0 mM
¹H and ¹³C NMR monitoring, 23040 min; 17436 min after mAc addition pP: 4.81 mM; pDAc: 71.5 mM; mAc: 531 mM; pPmAn: 11.6 mM; mAn: 9.42 mM
¹H and ¹³C NMR monitoring, 24437 min; 18833 min after mAc addition pP: 2.99 mM; pDAc: 73.1 mM; mAc: 532 mM; pPmAn: 9.86 mM; mAn: 9.24 mM
¹H and ¹³C NMR monitoring, 25910 min; 20306 min after mAc addition pP: 4.07 mM; pDAc: 83.3 mM; mAc: 596 mM; pPmAn: 12.3 mM; mAn: 8.81 mM
¹H and ¹³C NMR monitoring, 27308 min; 21704 min after mAc addition pP: 4.11 mM; pDAc: 80.3 mM; mAc: 584 mM; pPmAn: 11.5 mM; mAn: 8.87 mM
¹H and ¹³C NMR monitoring, 34599 min; 28995 min after mAc addition pP: 4.89 mM; pDAc: 81.4 mM; mAc: 539 mM; pPmAn: 6.16 mM; mAn: 5.01 mM
Main, p. 10; SI, pp. S3, S10–S11
Addition of 10.0 equiv. mAc to pP
NMR concentration definition For the polymers, apparent concentrations of the anhydride functional groups were monitored, not polymer chains
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H and ¹³C NMR monitoring, sample pAc (102 mM), pyridine-d₅ (62 mM), ethylene carbonate (105 mM), one equiv. EDC (104 mM), and mAc (1028 mM) in 80:20 acetone-d₆:D₂O at rt
¹³C NMR quantitation signals and calibration factors pP: 166.74 ppm, c 0.434/2; pDAc: 134.2 ppm, c 0.093; mAc: 124.64 ppm, c 0.544; pPmAn: 167 ppm, c 0.434; mAn: 124.20 ppm, c 0.6/2
¹H and ¹³C NMR monitoring, 62 min pP: 46.4 mM; pDAc: 14.0 mM; mAc: --; pPmAn: --; mAn: --
¹H and ¹³C NMR monitoring, 5619 min pP: 43.8 mM; pDAc: 17.4 mM; mAc: --; pPmAn: --; mAn: --
¹H and ¹³C NMR monitoring, 5682 min; 78 min after mAc addition pP: 35.1 mM; pDAc: 12.8 mM; mAc: 924 mM; pPmAn: 0 mM; mAn: 0 mM
¹H and ¹³C NMR monitoring, 7126 min; 1522 min after mAc addition pP: 27.6 mM; pDAc: 18.4 mM; mAc: 925 mM; pPmAn: 0 mM; mAn: 0 mM
¹H and ¹³C NMR monitoring, 8517 min; 2913 min after mAc addition pP: 24.1 mM; pDAc: 25.6 mM; mAc: 900 mM; pPmAn: 34.9 mM; mAn: 10.5 mM
¹H and ¹³C NMR monitoring, 10002 min; 4398 min after mAc addition pP: 18.0 mM; pDAc: 31.2 mM; mAc: 808 mM; pPmAn: 34.6 mM; mAn: 10.4 mM
¹H and ¹³C NMR monitoring, 11558 min; 5954 min after mAc addition pP: 12.9 mM; pDAc: 33.9 mM; mAc: 753 mM; pPmAn: 46.8 mM; mAn: 14.1 mM
¹H and ¹³C NMR monitoring, 13388 min; 7784 min after mAc addition pP: 11.3 mM; pDAc: 40.6 mM; mAc: 783 mM; pPmAn: 52.1 mM; mAn: 15.6 mM
¹H and ¹³C NMR monitoring, 14546 min; 8942 min after mAc addition pP: 11.0 mM; pDAc: 41.4 mM; mAc: 742 mM; pPmAn: 64.1 mM; mAn: 19.2 mM
¹H and ¹³C NMR monitoring, 16162 min; 10558 min after mAc addition pP: 8.66 mM; pDAc: 43.7 mM; mAc: 757 mM; pPmAn: 67.5 mM; mAn: 20.3 mM
¹H and ¹³C NMR monitoring, 17390 min; 11786 min after mAc addition pP: 8.88 mM; pDAc: 54.9 mM; mAc: 907 mM; pPmAn: 81.0 mM; mAn: 24.3 mM
¹H and ¹³C NMR monitoring, 18971 min; 13367 min after mAc addition pP: 7.10 mM; pDAc: 53.2 mM; mAc: 831 mM; pPmAn: 65.7 mM; mAn: 19.7 mM
¹H and ¹³C NMR monitoring, 20324 min; 14720 min after mAc addition pP: 5.34 mM; pDAc: 58.8 mM; mAc: 863 mM; pPmAn: 76.7 mM; mAn: 23.0 mM
¹H and ¹³C NMR monitoring, 21769 min; 16165 min after mAc addition pP: 3.94 mM; pDAc: 47.8 mM; mAc: 703 mM; pPmAn: 55.4 mM; mAn: 16.6 mM
¹H and ¹³C NMR monitoring, 23382 min; 17778 min after mAc addition pP: 5.03 mM; pDAc: 60.5 mM; mAc: 842 mM; pPmAn: 67.3 mM; mAn: 20.2 mM
¹H and ¹³C NMR monitoring, 26089 min; 20485 min after mAc addition pP: 5.54 mM; pDAc: 65.2 mM; mAc: 932 mM; pPmAn: 70.7 mM; mAn: 21.2 mM
¹H and ¹³C NMR monitoring, 27667 min; 22063 min after mAc addition pP: 4.84 mM; pDAc: 56.5 mM; mAc: 808 mM; pPmAn: 61.2 mM; mAn: 18.3 mM
¹H and ¹³C NMR monitoring, 28959 min; 23355 min after mAc addition pP: 4.11 mM; pDAc: 54.2 mM; mAc: 755 mM; pPmAn: 55.2 mM; mAn: 16.5 mM
¹H and ¹³C NMR monitoring, 32122 min; 26518 min after mAc addition pP: 1.04 mM; pDAc: 57.8 mM; mAc: 787 mM; pPmAn: 52.6 mM; mAn: 15.8 mM
¹H and ¹³C NMR monitoring, 34595 min; 28991 min after mAc addition pP: 2.38 mM; pDAc: 63.2 mM; mAc: 822 mM; pPmAn: 55.8 mM; mAn: 16.7 mM
¹H and ¹³C NMR monitoring, 40663 min; 35059 min after mAc addition pP: 0 mM; pDAc: 68.4 mM; mAc: 893 mM; pPmAn: 49.7 mM; mAn: 14.9 mM
Main, p. 10; SI, pp. S3, S11–S12
Addition of 0.1 equiv. AcOH to pP
NMR concentration definition For the polymers, apparent concentrations of the anhydride functional groups were monitored, not polymer chains
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H NMR monitoring, sample pDAc (101 mM), pyridine-d₅ (61 mM), ethylene carbonate (103 mM), one equiv. EDC (102 mM), and AcOH (10 mM) in 80:20 acetone-d₆:D₂O at rt
¹H NMR quantitation signals pP: 8.18 ppm; pDAc: 8.07 ppm; AcOH: 2.08 ppm
¹H NMR monitoring, 107 min pP: 44.3 mM; pDAc: 19.4 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5856 min pP: 42.5 mM; pDAc: 22.8 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5947 min; 61 min after AcOH addition pP: 42.0 mM; pDAc: 24.1 mM; AcOH: 8.29 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 7238 min; 1352 min after AcOH addition pP: 40.4 mM; pDAc: 27.4 mM; AcOH: 9.00 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 8693 min; 2807 min after AcOH addition pP: 38.4 mM; pDAc: 30.4 mM; AcOH: 8.32 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 10058 min; 4172 min after AcOH addition pP: 37.3 mM; pDAc: 33.5 mM; AcOH: 9.16 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 11548 min; 5662 min after AcOH addition pP: 35.4 mM; pDAc: 36.4 mM; AcOH: 7.97 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 13014 min; 7128 min after AcOH addition pP: 34.2 mM; pDAc: 38.5 mM; AcOH: 8.51 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 14467 min; 8581 min after AcOH addition pP: 33.0 mM; pDAc: 41.3 mM; AcOH: 8.53 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 17412 min; 11526 min after AcOH addition pP: 31.5 mM; pDAc: 45.1 mM; AcOH: 9.20 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 20365 min; 14479 min after AcOH addition pP: 29.4 mM; pDAc: 48.6 mM; AcOH: 9.21 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 27551 min; 21665 min after AcOH addition pP: 27.5 mM; pDAc: 53.2 mM; AcOH: 9.01 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 31608 min; 25722 min after AcOH addition pP: 23.0 mM; pDAc: 60.6 mM; AcOH: 8.57 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 35899 min; 30013 min after AcOH addition pP: 21.2 mM; pDAc: 63.5 mM; AcOH: 7.85 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 48928 min; 43042 min after AcOH addition pP: 15.8 mM; pDAc: 71.6 mM; AcOH: 5.63 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 53097 min; 47211 min after AcOH addition pP: 14.1 mM; pDAc: 75.1 mM; AcOH: 4.76 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 57852 min; 51966 min after AcOH addition pP: 10.6 mM; pDAc: 81.2 mM; AcOH: 5.37 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
Main, p. 10; SI, pp. S3, S12–S13
Addition of 0.3 equiv. AcOH to pP
NMR concentration definition For the polymers, apparent concentrations of the anhydride functional groups were monitored, not polymer chains
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H NMR monitoring, sample pDAc (101 mM), pyridine-d₅ (61 mM), ethylene carbonate (103 mM), one equiv. EDC (102 mM), and AcOH (32 mM) in 80:20 acetone-d₆:D₂O at rt
¹H NMR quantitation signals pP: 8.18 ppm; pDAc: 8.07 ppm; AcOH: 2.08 ppm
¹H NMR monitoring, 107 min pP: 44.3 mM; pDAc: 19.4 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5856 min pP: 42.5 mM; pDAc: 22.8 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5954 min; 66 min after AcOH addition pP: 42.2 mM; pDAc: 23.4 mM; AcOH: 76.8 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 7245 min; 1357 min after AcOH addition pP: 37.7 mM; pDAc: 32.3 mM; AcOH: 76.4 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 8712 min; 2824 min after AcOH addition pP: 34.0 mM; pDAc: 39.1 mM; AcOH: 76.5 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 10066 min; 4178 min after AcOH addition pP: 31.2 mM; pDAc: 44.7 mM; AcOH: 76.5 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 11555 min; 5667 min after AcOH addition pP: 28.7 mM; pDAc: 49.7 mM; AcOH: 76.5 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 13022 min; 7134 min after AcOH addition pP: 26.3 mM; pDAc: 54.3 mM; AcOH: 76.7 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 14482 min; 8594 min after AcOH addition pP: 24.7 mM; pDAc: 57.6 mM; AcOH: 77.4 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 17429 min; 11541 min after AcOH addition pP: 22.0 mM; pDAc: 63.9 mM; AcOH: 76.8 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 20372 min; 14484 min after AcOH addition pP: 19.3 mM; pDAc: 68.8 mM; AcOH: 76.5 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 27558 min; 21670 min after AcOH addition pP: 14.0 mM; pDAc: 78.0 mM; AcOH: 76.0 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 31616 min; 25728 min after AcOH addition pP: 11.9 mM; pDAc: 83.1 mM; AcOH: 76.5 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 35907 min; 30019 min after AcOH addition pP: 9.66 mM; pDAc: 85.1 mM; AcOH: 74.6 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 53106 min; 47218 min after AcOH addition pP: 4.91 mM; pDAc: 96.0 mM; AcOH: 75.9 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 57843 min; 51955 min after AcOH addition pP: 3.19 mM; pDAc: 98.7 mM; AcOH: 75.0 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
Main, p. 10; SI, pp. S3, S13–S14
Addition of 1.0 equiv. AcOH to pP
NMR concentration definition For the polymers, apparent concentrations of the anhydride functional groups were monitored, not polymer chains
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H NMR monitoring, sample pDAc (101 mM), pyridine-d₅ (63 mM), ethylene carbonate (103 mM), one equiv. EDC (104 mM), and AcOH (118 mM) in 80:20 acetone-d₆:D₂O at rt
¹H NMR quantitation signals pP: 8.18 ppm; pDAc: 8.07 ppm; AcOH: 2.08 ppm
¹H NMR monitoring, 70 min pP: 45.2 mM; pDAc: 16.2 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5492 min pP: 43.0 mM; pDAc: 20.0 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5604 min; 62 min after AcOH addition pP: 42.2 mM; pDAc: 21.0 mM; AcOH: 102 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 7340 min; 1798 min after AcOH addition pP: 30.8 mM; pDAc: 43.7 mM; AcOH: 101 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 8676 min; 3134 min after AcOH addition pP: 25.0 mM; pDAc: 54.8 mM; AcOH: 103 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 10199 min; 4657 min after AcOH addition pP: 20.1 mM; pDAc: 64.2 mM; AcOH: 100 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 11624 min; 6082 min after AcOH addition pP: 17.0 mM; pDAc: 71.5 mM; AcOH: 102 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 14227 min; 8685 min after AcOH addition pP: 12.3 mM; pDAc: 81.0 mM; AcOH: 104 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 16117 min; 10575 min after AcOH addition pP: 9.7.0 mM; pDAc: 84.4 mM; AcOH: 101 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 17587 min; 12045 min after AcOH addition pP: 8.30 mM; pDAc: 87.5 mM; AcOH: 103 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 19044 min; 13502 min after AcOH addition pP: 7.15 mM; pDAc: 89.7 mM; AcOH: 101 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 20407 min; 14865 min after AcOH addition pP: 6.13 mM; pDAc: 91.3 mM; AcOH: 102 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 21897 min; 16355 min after AcOH addition pP: 5.14 mM; pDAc: 93.0 mM; AcOH: 101 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 23362 min; 17820 min after AcOH addition pP: 4.38 mM; pDAc: 94.5 mM; AcOH: 101 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
Main, p. 10; SI, pp. S3, S14–S15
Addition of 2.0 equiv. AcOH to pP
NMR concentration definition For the polymers, apparent concentrations of the anhydride functional groups were monitored, not polymer chains
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H NMR monitoring, sample pDAc (102 mM), pyridine-d₅ (63 mM), ethylene carbonate (104 mM), one equiv. EDC (104 mM), and AcOH (242 mM) in 80:20 acetone-d₆:D₂O at rt
¹H NMR quantitation signals pP: 8.18 ppm; pDAc: 8.07 ppm; AcOH: 2.08 ppm
¹H NMR monitoring, 72 min pP: 44.4 mM; pDAc: 18.3 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5496 min pP: 42.6 mM; pDAc: 21.9 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5615 min; 74 min after AcOH addition pP: 41.1 mM; pDAc: 23.6 mM; AcOH: 246 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 7343 min; 1802 min after AcOH addition pP: 25.9 mM; pDAc: 53.4 mM; AcOH: 244 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 8687 min; 3146 min after AcOH addition pP: 19.2 mM; pDAc: 68.0 mM; AcOH: 249 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 10203 min; 4662 min after AcOH addition pP: 13.9 mM; pDAc: 78.1 mM; AcOH: 249 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 11629 min; 6088 min after AcOH addition pP: 10.4 mM; pDAc: 85.2 mM; AcOH: 249 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 14231 min; 8690 min after AcOH addition pP: 6.10 mM; pDAc: 92.9 mM; AcOH: 245 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 16122 min; 10581 min after AcOH addition pP: 4.28 mM; pDAc: 95.4 mM; AcOH: 244 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 17595 min; 12054 min after AcOH addition pP: 3.06 mM; pDAc: 99.0 mM; AcOH: 250 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
Main, p. 10; SI, pp. S3, S15–S16
Addition of 5.0 equiv. AcOH to pP
NMR concentration definition For the polymers, apparent concentrations of the anhydride functional groups were monitored, not polymer chains
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H NMR monitoring, sample pAc (101 mM), pyridine-d₅ (59 mM), ethylene carbonate (102 mM), one equiv. EDC (104 mM), and AcOH (541 mM) in 80:20 acetone-d₆:D₂O at rt
¹H NMR quantitation signals pP: 8.18 ppm; pDAc: 8.07 ppm; AcOH: 2.08 ppm
¹H NMR monitoring, 64 min pP: 46.4 mM; pDAc: 19.4 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5644 min pP: 45.1 mM; pDAc: 21.7 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5714 min; 58 min after AcOH addition pP: 43.8 mM; pDAc: 22.6 mM; AcOH: 562 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 7023 min; 1367 min after AcOH addition pP: 32.4 mM; pDAc: 43.5 mM; AcOH: 544 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 8617 min; 2961 min after AcOH addition pP: 23.3 mM; pDAc: 62.6 mM; AcOH: 542 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 10056 min; 4400 min after AcOH addition pP: 17.4 mM; pDAc: 74.4 mM; AcOH: 544 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 11374 min; 5718 min after AcOH addition pP: 13.5 mM; pDAc: 82.0 mM; AcOH: 549 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 12916 min; 7260 min after AcOH addition pP: 9.99 mM; pDAc: 87.7 mM; AcOH: 555 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 14406 min; 8750 min after AcOH addition pP: 7.16 mM; pDAc: 93.6 mM; AcOH: 551 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 15722 min; 10066 min after AcOH addition pP: 5.36 mM; pDAc: 99.0 mM; AcOH: 571 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 16966 min; 11310 min after AcOH addition pP: 3.75 mM; pDAc: 100 mM; AcOH: 562 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 18716 min; 13060 min after AcOH addition pP: 2.85 mM; pDAc: 101 mM; AcOH: 544 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 20135 min; 14479 min after AcOH addition pP: 2.10 mM; pDAc: 101 mM; AcOH: 536 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 28916 min; 23260 min after AcOH addition pP: 0 mM; pDAc: 103 mM; AcOH: 531 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
Main, p. 10; SI, pp. S3, S16–S17
Addition of 10.0 equiv. AcOH to pP
NMR concentration definition For the polymers, apparent concentrations of the anhydride functional groups were monitored, not polymer chains
NMR reporting reference Calibrated using residual undeuterated solvent as an internal reference (CD₃COCD₃ δ 2.09 and 30.60 ppm) and reported in parts per million relative to trimethylsilane (TMS, δ 0.00 ppm)
¹H NMR monitoring, sample pAc (101 mM), pyridine-d₅ (61 mM), ethylene carbonate (102 mM), one equiv. EDC (104 mM), and AcOH (1134 mM) in 80:20 acetone-d₆:D₂O at rt
¹H NMR quantitation signals pP: 8.18 ppm; pDAc: 8.07 ppm; AcOH: 2.08 ppm
¹H NMR monitoring, 59 min pP: 44.8 mM; pDAc: 14.1 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5765 min pP: 43.0 mM; pDAc: 17.7 mM; AcOH: --; pPAcAn: --; Ac₂O: --
¹H NMR monitoring, 5828 min; 75 min after AcOH addition pP: 42.1 mM; pDAc: 21.7 mM; AcOH: 1240 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 7141 min; 1388 min after AcOH addition pP: 28.1 mM; pDAc: 47.0 mM; AcOH: 1190 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 8843 min; 3090 min after AcOH addition pP: 17.8 mM; pDAc: 68.5 mM; AcOH: 1220 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 10038 min; 4285 min after AcOH addition pP: 12.9 mM; pDAc: 78.9 mM; AcOH: 1230 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 11557 min; 5804 min after AcOH addition pP: 8.54 mM; pDAc: 86.8 mM; AcOH: 1210 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 12907 min; 7154 min after AcOH addition pP: 6.08 mM; pDAc: 92.1 mM; AcOH: 1200 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 14461 min; 8708 min after AcOH addition pP: 3.80 mM; pDAc: 96.8 mM; AcOH: 1220 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
¹H NMR monitoring, 17458 min; 11705 min after AcOH addition pP: 1.77 mM; pDAc: 100.5 mM; AcOH: 1210 mM; pPAcAn: 0 mM; Ac₂O: 0 mM
Main, p. 10; SI, pp. S3, S17–S18
Kinetic fit for mAc added to pAn
NMR reporting qualifier ¹³C NMR signal intensities were calibrated against concentrations measured by ¹H NMR; calibration factors for pmAn were assumed identical to those of pAn or mAn depending on which side of pmAn was considered; [pAc] + 2[pAn] + [pmAn] was verified as constant; because of the assumption and ¹³C NMR signal-to-noise, the results should be treated as semi-quantitative and as broad estimates of rate constants
Experimental kinetic fit, basis Four-parameter simultaneous fit using the steady-state approximation in pI and mI
Experimental kinetic fit, parameter definitions k₁ and k₂ are the rates of attack by pyridine on pAn and mAn, respectively; α₁ = k₃/k₋₁ and α₂ = k₄/k₋₂ represent partitioning of the corresponding intermediates between hydrolysis and exchange
Experimental kinetic fit, residual weighting kinmodel optionally weights residuals by 1/C, where C is the concentration of interest; lower bound on C: 5 mM
Experimental kinetic fit, k₁ 2.4 (+0.3/−0.5) × 10⁻⁴ min⁻¹
Experimental kinetic fit, k₂ 3.9 (+0.6/−1.2) × 10⁻⁴ min⁻¹
Experimental kinetic fit, α₁ 0.7 (+0.3/−0.1) mM
Experimental kinetic fit, α₂ 140 (+80/−20) mM
Experimental kinetic fit, uncertainty estimation 95 % confidence interval from 10,000 non-parametric random-x bootstrap iterations, corresponding to the 2.5 % and 97.5 % entries in the ranked results
Main, pp. 6–9; SI, pp. S21–S22
Kinetic fit for mAc added to pP
NMR concentration definition For the polymers, apparent concentrations of the anhydride functional groups were monitored, not polymer chains
NMR reporting qualifier Because of inherent challenges of monitoring kinetics by ¹³C NMR, including signal-to-noise, the results should be treated as semi-quantitative and as broad estimates of rate constants
Experimental kinetic fit, basis Four-parameter simultaneous fit using the steady-state approximation
Experimental kinetic fit, parameter definitions k₁ and k₂ are the rates of attack by pyridine on pP and mAn, respectively; α₁ = k₃/k₋₁ and α₂ = k₄/k₋₂ represent partitioning of the corresponding intermediates between hydrolysis and exchange
Experimental kinetic fit, residual weighting kinmodel optionally weights residuals by 1/C, where C is the concentration of interest; lower bound on C: 5 mM
Experimental kinetic fit, k₁ 1.3 (+0.2/−0.2) × 10⁻⁴ min⁻¹
Experimental kinetic fit, k₂ 1.3 (+0.5/−0.5) × 10⁻⁴ min⁻¹
Experimental kinetic fit, α₁ 1.2 (+0.3/−0.2) mM
Experimental kinetic fit, α₂ 200 (+100/−100) mM
Experimental kinetic fit, uncertainty estimation 95 % confidence interval from 10,000 non-parametric random-x bootstrap iterations, corresponding to the 2.5 % and 97.5 % entries in the ranked results
Main, pp. 6, 9–10; SI, pp. S21–S22, S32–S34
Kinetic fit for AcOH added to pP
NMR concentration definition For the polymers, apparent concentrations of the anhydride functional groups were monitored, not polymer chains
Experimental kinetic fit, basis Four-parameter simultaneous fit using the steady-state approximation
Experimental kinetic fit, parameter definitions k₁ and k₂ are the rates of attack by pyridine on pP and Ac₂O, respectively; α₁ = k₃/k₋₁ and α₂ = k₄/k₋₂ represent partitioning of the corresponding intermediates between hydrolysis and exchange
Experimental kinetic fit, residual weighting kinmodel optionally weights residuals by 1/C, where C is the concentration of interest; lower bound on C: 5 mM
Experimental kinetic fit, k₁ 2.3 (+0.1/−0.1) × 10⁻⁴ min⁻¹
Experimental kinetic fit, k₂ 500 (+500/−400) min⁻¹
Experimental kinetic fit, α₁ 0.6 (+0.1/−0.3) mM
Experimental kinetic fit, α₂ 11 (+116/−7) mM
Experimental kinetic fit, reporting qualifier Uncertainties in k₂ and α₂ are large because two of the anhydrides were not observed
Experimental kinetic fit, parameter-determination qualifier k₂ and α₂ are not determined by the data
Experimental kinetic fit, uncertainty estimation 95 % confidence interval from 10,000 non-parametric random-x bootstrap iterations, corresponding to the 2.5 % and 97.5 % entries in the ranked results